SCHEMBL1429888

SCHEMBL1429888

Cc1ccc(F)cc1-c1cc(CN2CCC3(CC2C)CN(C)S(=O)(=O)N3c2cccc(F)c2)ccc1O

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171014 1.00 BACE1 (0.77) BACE1
SCHEMBL1170699 0.95 BACE1 (0.76) BACE1
SCHEMBL1429566 0.95 BACE1 (0.76) BACE1
SCHEMBL1429788 0.95 BACE1 (0.76) BACE1
SCHEMBL1170407 0.95 BACE1 (0.76) BACE1
SCHEMBL1171011 0.92 BACE1 (0.65) BACE1
SCHEMBL1429884 0.91 BACE1 (0.77) BACE1
SCHEMBL1170840 0.91 BACE1 (0.77) BACE1
SCHEMBL1429553 0.89 BACE1 (0.75) BACE1
SCHEMBL1170526 0.89 BACE1 (0.75) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300484-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Pfizer Inc. (US) 2011-03-30 EP claimed
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO claimed